Class IITerminatedD-1875-2019
Drug recall · September 18, 2019
AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg recall
Why: Failed Stability Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.
- Lots / codes
Lot #s: 067180011A; 067180012A, Exp. 04/2021; 06718027B1 Exp. 09/2021
- Quantity
- 5953 bottles
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide in the U.S.
- Initiated
- August 28, 2019 · Voluntary: Firm initiated
- Classified
- September 17, 2019
- Reported
- September 18, 2019
- Ended
- October 27, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.